Measuring health related quality of life: An international perspective

Advances in Experimental Medicine and Biology

Volumn 528, Issue , 2003, Pages 113-122

  Bullinger, Monika ^a  

^a UNIVERSITY OF HAMBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

COPING BEHAVIOR; HEALTH CARE DELIVERY; HEALTH CARE QUALITY; HEALTH STATUS; HUMAN; MEDICAL RESEARCH; PATIENT ATTITUDE; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; SELF REPORT; SOCIAL BEHAVIOR; SOCIAL SUPPORT; QUESTIONNAIRE;

HEALTH STATUS; HUMANS; QUALITY OF LIFE; QUESTIONNAIRES;

EID: 0642308150     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Review

References (34)

1. Najman, J.M., and Levine, S., 1981, Evaluating the impact of medical care and technology on quality of life. A review and critique. Sac. Sci. Med. 15F: 107-115.
2. Patrick, D.L., and Erickson, P., 1992, Health status and health policy. Oxford University Press, New York.
3. Bullinger, M., 1997, Health- related quality of life and subjective health. Psychother. Psychosom. Med. Psychol. 47: 76-91.
4. Spilker, B., 1996, Quality of life assessment in clinical trails. Raven Press, New York.
5. Cambell, I., 1981, The quality of American life. Russel-Sage, New York.
6. Glatzer, W., and Zapf, W., 1984, Lebensqualität in der Bundesrepublik Deutschland. Campus: Frankfurt.
7. Guyatt, G.H., Feeny, D.H., and Patrick, D.L., 1993, Measuring health-related quality of life. Ann. Intern. Med. 118: 622-629.
8. Lydick, E.G., and Epstein, R.S., 1996, Clinical significance of quality of life data. In Quality of life and pharmaeconomics in clinical trials (B. Spilker, ed.), Lippincott-Raven, Philadelphia, pp. 461-466.
9. Schipper, H., Clinch, J. J., and Olweny, Ch.L.M., 1996, Quality of life studies. Definition and conceptual issues. In Quality of life and pharmaeconomics in clinical trials (B. Spilker, ed.), Lippincott-Raven, Philadelphia, pp. 11-24.
10. Bullinger, M., 1991, Quality of life- Definition, conceptualization and implications. A methodologists view. Theor. Surgery 6: 143-148.
11. Ludwig, M., 1991, Implizite Therapiebildung in der Lebensqualität. In Lebensqualität bei kardiovaskulären Erkrankungen (M. Bullinger, M. Ludwig, und N. von Steinbüchel, Hrsg.), Hogrefe, Stuttgart, pp. 3-12.
12. Bowling, A., 1991, Measuring health. A review of quality of life measurement scales. Milton Keynes, Open University Press, Philadelphia.
13. Bullinger, M., Power, M.J., Aaronson, N.K., et al., 1996, Creating and evaluating cross-cultural instruments. In Quality of life and pharmaeconomics in clinical trials (B. Spilker, ed.), Lippincott-Raven, Philadelphia, pp. 659-668.
14. Aaronson, N.K., Cull, A.M., Stein K., et al., 1996, The European organization for research and treatment of cancer (EORTC). Modular approach to quality of life assessment in oncology. An update. In Quality of life and pharmaeconomics in clinical trials (B. Spilker, ed.), Lippincott-Raven, Philadelphia, pp. 179-190.
15. Hunt, S.M., McEwen, J., McKenna, S.P., et al. 1981, The Nottingham health profile. Subjective health status and medical consultations. Soc. Sci. Med. 15A: 221-229.
16. Ware, J.E., 1996, The SF-36 health survey.. In Quality of life and pharmaeconomics in clinical trials (B. Spilker, ed.), Lippincott-Raven, Philadelphia, pp. 337-346.
17. Orley, J. and the WHOQOL-Group, 1994, The development of the WHO quality of life assessment instruments (The WHOQOL). In Quality of life assessment, international perspectives (J. Orley, and W. Kuyken, eds.), Springer, Berlin, pp. 41-57.
18. Ware, J.E., 1987, Standards for validating health measures. Definition and content. J. Chronic Dis. 40: 503-512.
19. Cella, D.F., and Bonomi, A.E., 1996, The functional assessment of cancer therapy (FACT) and functional assessment of HIV infection (FAHI) quality of life measurement system. In Quality of life and pharmaeconomics in clinical trials (B. Spilker, ed.), Lippincott-Raven, Philadelphia, pp. 203-214.
20. Bullinger, M., 1997, The challenge of cross- cultural quality of life assessment. Psychol. Health 12: 815-825.
21. Kornblith, A.B., Hollis, D.R., Zuckerman, E., et al., 1993, Effect of megestrol acetate on quality of life in a dose-response trial in women with advanced breast cancer. The cancer and leukemia group B. J. Clin. Oncol. 11: 2081-2089.
22. Bulpitt, C.J., Fletcher, A.E., 1994, Quality of life and the heart. Evaluation of therapeutic alternatives. Br. J. Clin. Practice 73 (suppl.): 18-22.
23. Croog, S.H., Levine, S., and Testa, M.A., 1986, The effect of antihypertensive therapy on the quality of life. N. Engl. J. Med. 314: 1657-1664.
24. Wiklund, L, Gorkin, L., Pawitan, Y., et al., 1992, Methods for assessing quality of life in the cardiac arrhythmia suppression trial (CAST). Quality Life Res. 1: 187-201.
25. Ekeberg, O., Klemsdal, T.O., and Kjeldsen, S.E., 1994, Quality of life on enalapril after acute myocardial infarction. Eur. Heart J. 15: 1135-1139.
26. Naber, D., 1998, Subjective experiences of schizophrenic patients treated with antipsychotic medication. Int. J. Clin. Psychopharmacol. 13 (suppl. 1): 41-45.
27. Wagner, A.K., and Vickrey, B.C., 1995, The routine use of health-related quality of life measures in the care of patients with epilepsy. Rationale and research agenda. Quality Life Res., 4: 169-177.
28. Dodrill, C.B., Arnett, J.L., Sommerville, K. W., et al., 1995,. Effects of differing dosages of vigabatrin (Sabril) on cognitive abilities and qualities of life in epilepsy. Epilepsia 36: 164-173.
29. McMahon, L.P., and Dawborn, J.K., 1992, Subjective quality of life assessment in hemodialysis patients at different levels of hemoglobin following use of recombinant human erythropoietin. Am. J. Nephrol. 12: 162-169.
30. Solomon, G.D., Skobieranda, F.G., and Gragg, L.A., 1993, Quality of life and wellbeing of headache patients. Measurement by the medical outcomes study instrument. Headache 33: 351-358.
31. Cunningham, W.E., Hays, R.D., Williams, K.W., et al., 1995, Access to medical care and health-related quality of life for low-income persons with symptomatic human immunodeficiency virus. Med. Care 33: 739-754.
32. Revicki, D.A., Brown, R.E., Henry, D.H., et al., 1994, Recombinant human erythropoietin and health-related quality of life of AIDS patients with anemia. AIDS 7: 474-484.
33. Troidl, H., Wood-Dauphinee, S., and Williams, I., 1980, Endpoints in surgical trials. Thieme, New York.
34. Joyce, C.R., 1994, Health status or quality of life. Which matters to the patient? J. Cardiovasc. Pharmacol. 23: S26-S33.